Login / Signup
An alternative way - tyrosine kinase inhibitor (TKI) de-escalation - to discontinue TKIs in order to achieve treatment-free remission.
Ahmad Kunbaz
Ahmet Emre Eskazan
Published in:
Expert review of hematology (2019)
Keyphrases
</>
tyrosine kinase
open label
randomized controlled trial
advanced non small cell lung cancer
disease activity
systemic lupus erythematosus
replacement therapy